Home » Topics » Regulatory

Regulatory
RSS

FDA grants approval to Spinraza for treatment of spinal muscular atrophy

Dec. 27, 2016

FDA approves Rubraca and companion diagnostic for ovarian cancer

Dec. 20, 2016

BMS's Ximency receives first approval in Japan

Dec. 19, 2016

FDA approves Eucrisa for atopic dermatitis

Dec. 15, 2016

European Commission approves Ferring's Rekovelle

Dec. 14, 2016

FDA approves Avastin for platinum-sensitive ovarian cancer

Dec. 7, 2016

European Commission approves Lucentis for sixth indication

Dec. 7, 2016

FDA approves new indication for Jardiance

Dec. 5, 2016

Mochida obtains Japanese approval for Dinagest for adenomyosis

Dec. 5, 2016

FDA approves Soliqua for type 2 diabetes

Nov. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 12, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...